A Phase II Study of Palbociclib for Recurrent or Refractory Advanced Thymic Epithelial Tumor
Clinical trial NCT03219554 · UNKNOWN
Trial details
- NCT number
- NCT03219554
- Sponsor
- Samsung Medical Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-01
- Primary completion
- 2019-12-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.